187 related articles for article (PubMed ID: 32592343)
1. Association of TP53 Codon 72 Arg>Pro Polymorphism with Breast and Lung Cancer Risk in the South Asian Population: A Meta-Analysis.
Jafrin S; Aziz MA; Anonna SN; Akter T; Naznin NE; Reza S; Islam MS
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1511-1519. PubMed ID: 32592343
[TBL] [Abstract][Full Text] [Related]
2. p.Arg72Pro polymorphism of P53 and breast cancer risk: a meta-analysis of case-control studies.
Diakite B; Kassogue Y; Dolo G; Wang J; Neuschler E; Kassogue O; Keita ML; Traore CB; Kamate B; Dembele E; Nadifi S; Murphy RL; Doumbia S; Hou L; Maiga M
BMC Med Genet; 2020 Oct; 21(1):206. PubMed ID: 33076844
[TBL] [Abstract][Full Text] [Related]
3. Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population.
Mostaid MS; Ahmed MU; Islam MS; Bin Sayeed MS; Hasnat A
Tumour Biol; 2014 Oct; 35(10):10309-17. PubMed ID: 25034526
[TBL] [Abstract][Full Text] [Related]
4. TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis.
Jiang DK; Yao L; Wang WZ; Peng B; Ren WH; Yang XM; Yu L
World J Gastroenterol; 2011 Mar; 17(9):1227-33. PubMed ID: 21448430
[TBL] [Abstract][Full Text] [Related]
5. P53 codon 72 Arg/Pro polymorphism and lung cancer risk in Asians: an updated meta-analysis.
Wang S; Lan X; Tan S; Wang S; Li Y
Tumour Biol; 2013 Oct; 34(5):2511-20. PubMed ID: 23812725
[TBL] [Abstract][Full Text] [Related]
6. Association between p53 codon 72 polymorphism and cervical cancer risk among Asians: a HuGE review and meta-analysis.
Zhou X; Gu Y; Zhang SL
Asian Pac J Cancer Prev; 2012; 13(10):4909-14. PubMed ID: 23244080
[TBL] [Abstract][Full Text] [Related]
7. TP53 codon 72 polymorphism and breast cancer risk in Bangladeshi population.
Hossain A; Murshid GMM; Zilani MNH; Islam F; Sultana R; Sultana T; Hossain MG; Rahman MM
Breast Cancer; 2017 Jul; 24(4):571-578. PubMed ID: 27837441
[TBL] [Abstract][Full Text] [Related]
8. TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis.
Jiang DK; Yao L; Ren WH; Wang WZ; Peng B; Yu L
Med Oncol; 2011 Dec; 28(4):1129-35. PubMed ID: 20552298
[TBL] [Abstract][Full Text] [Related]
9. Association between p53 polymorphism at codon 72 and recurrent spontaneous abortion.
Zhang Y; Wu YY; Qiao FY; Zeng WJ
J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):402-405. PubMed ID: 27376811
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the association between p53 codon 72 Arg>pro polymorphism and risk of ovary cancer: a meta-analysis.
Alqumber MA; Akhter N; Haque S; Panda AK; Mandal RK
PLoS One; 2014; 9(4):e94874. PubMed ID: 24747975
[TBL] [Abstract][Full Text] [Related]
11. TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis.
Wang JJ; Zheng Y; Sun L; Wang L; Yu PB; Dong JH; Zhang L; Xu J; Shi W; Ren YC
Mol Biol Rep; 2011 Nov; 38(8):4847-53. PubMed ID: 21140221
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis shows significant association of the TP53 Arg72Pro with ovarian cancer risk.
Shen SQ; Jiang DK; Liu GY; Chen F; Yu L
Mol Biol Rep; 2012 Apr; 39(4):4683-90. PubMed ID: 21952824
[TBL] [Abstract][Full Text] [Related]
13. No significant association between the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis of 21 studies involving 24,063 subjects.
Ma Y; Yang J; Liu Z; Zhang P; Yang Z; Wang Y; Qin H
Breast Cancer Res Treat; 2011 Jan; 125(1):201-5. PubMed ID: 20496166
[TBL] [Abstract][Full Text] [Related]
14. P53 codon 72 polymorphism and lung cancer risk: evidence from 27,958 subjects.
Zhou C; Chen H; Wang A
Tumour Biol; 2013 Oct; 34(5):2961-9. PubMed ID: 23715779
[TBL] [Abstract][Full Text] [Related]
15. p53 codon 72 polymorphism and hematological cancer risk: an update meta-analysis.
Weng Y; Lu L; Yuan G; Guo J; Zhang Z; Xie X; Chen G; Zhang J
PLoS One; 2012; 7(9):e45820. PubMed ID: 23029260
[TBL] [Abstract][Full Text] [Related]
16. No Evidence of Association of the Arg72Pro p53 Gene Polymorphism with Cancer Risk in the Saudi Population: a Meta-Analysis.
Irshad M; Mandal RK; Al-Drees A; Khalil MS; Abdulghani HM
Asian Pac J Cancer Prev; 2015; 16(14):5663-7. PubMed ID: 26320432
[TBL] [Abstract][Full Text] [Related]
17. Association between the TP53 polymorphisms and lung cancer risk: a meta-analysis.
Ye XH; Bu ZB; Feng J; Peng L; Liao XB; Zhu XL; Sun XL; Yu HG; Yan DF; Yan SX
Mol Biol Rep; 2014 Jan; 41(1):373-85. PubMed ID: 24271138
[TBL] [Abstract][Full Text] [Related]
18. TP53 Arg72Pro and XPD Lys751Gln Gene Polymorphisms and Risk of Lung Cancer in Bangladeshi Patients.
Nairuz T; Rahman M; Bushra MU; Kabir Y
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2091-2098. PubMed ID: 32711437
[TBL] [Abstract][Full Text] [Related]
19. TP53 (rs1042522, rs28934571) and TP21 (rs1801270, rs1059234) Polymorphisms and Risk of Breast Cancer among Rural Women of Maharashtra: Findings from a Hospital Based Case- Control Study.
Datkhile KD; Bhosale SJ; Durgawale PP; Jagdale NJ; More AL; Gudur RA; Gudur AK; Patil SR
Asian Pac J Cancer Prev; 2023 May; 24(5):1611-1619. PubMed ID: 37247280
[TBL] [Abstract][Full Text] [Related]
20. No association of TP53 codon 72 and intron 3 16-bp duplication polymorphisms with breast cancer risk in Chinese Han women: new evidence from a population-based case-control investigation.
Hao W; Xu X; Shi H; Zhang C; Chen X
Eur J Med Res; 2018 Oct; 23(1):47. PubMed ID: 30309383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
